According to a new study “Scarring Body and Mind: The Long-Term Belief-Scarring Effects of COVID-19” the largest economic cost of the COVID-19 pandemic could arise from changes in behavior long after the immediate health crisis is resolved. A potential source of such a long-lived change is scarring of beliefs, a persistent change in the perceived probability of an extreme, negative shock in the future. Even if a vaccine cures everyone in a year, the COVID-19 crisis will leave its mark on the US economy for many years to come because of the mass revision of beliefs that lasts through a lifetime. Even before the COVID-19 pandemic, people were aware of the disruptive impacts that a pandemic could theoretically have on their lives and the economy. But the tangible, persistent and severe harms associated with an actual pandemic change beliefs about the probability of another similar shock in ways that abstract knowledge cannot.
Excerpts from Free Exchange: Razing Hopes, Economist, Aug. 29, 2020 [adapted]
On June 29, 2020 the US Department of Health and Human Services (HHS) announced an agreement to secure large supplies of the drug remdesivir for the United States from Gilead Sciences through September, allowing American hospitals to purchase the drug in amounts allocated by HHS and state health departments….HHS has secured more than 500,000 treatment courses of the drug for American hospitals through September. This represents 100% of Gilead’s projected production for July (94,200 treatment courses), 90% of production in August (174,900 treatment courses), and 90% of production in September (232,800 treatment courses), in addition to an allocation for clinical trials. A treatment course of remdesivir is, on average, 6.25 vials.
Hospitals will receive the product shipped by AmerisourceBergen and will pay no more than Gilead’s Wholesale Acquisition Price (WAC), which amounts to approximately $3,200 per treatment course.
Excerpts from Trump Administration Secures New Supplies of Remdesivir for the United States, June 29, 2020
Plastic bags may make a temporary comback in some places because of COVID-19. In a setback, albeit temporary, for efforts to combat plastic waste, many state and local governments have suspended plastic bag bans and are prohibiting the use of reusable bags to stem the spread of COVID-19. The plastics industry is pushing for such measures, causing environmentalists to cry foul. San Francisco, which has been at the forefront of single-use plastics restrictions, issued an order “not permitting customers to bring their own bags, mugs, or other reusable items from home” as a measure “to prevent unnecessary contact.” Maine is delaying enforcement of its plastic bag ban to Jan. 15, 2021, after originally planning to roll it out on April 22—Earth Day….
The plastics industry has been advocating for such measures. In recent weeks, Bag The Ban, an initiative sponsored by the American Recyclable Plastic Bag Alliance, has endorsed editorials in newspapers such as the Boston Herald and the New Hampshire Union Leader advocating use of plastic bags to protect grocery workers from COVID-19.
Writing to the US Department of Health and Human Services, the Plastics Industry Association made a similar point. “Single-use plastic products are the most sanitary choice when it comes to many applications.” The association cited research on reusable bags, including a 2011 study from Loma Linda University and the University of Arizona that tested bags from shoppers selected randomly at the grocery store and found bacteria such as E. coli on 8% of them. It also pointed to a 2012 outbreak of norovirus in Oregon linked to use of a reusable food bag and cited a 2019 study from Portugal that found bacteria in bags.
Alexander H. Tullo, Plastic bag bans rolled back for COVID-19, Apr. 7, 2020
“We don’t have a national plan,” says epidemiologist Michael Osterholm of the University of Minnesota, Twin Cities. “We are going from press conference to press conference and crisis to crisis … trying to understand our response.”…Even if lockdowns succeed at halting the virus…. the United States needs to marshal massive resources to monitor for new outbreaks and quickly contain them…. Identifying cases and contacts and isolating them will require a huge increase in public health workers at the local level….The absence of nationwide coordination highlights the division of legal power between the federal and state governments…. Governors, not federal officials, typically hold police powers to shut businesses and enforce curfews. But many are reluctant to invoke those powers and suffer the political costs without clear direction from above….“The closest comparison here, in terms of national mobilization, is a war. And there is no way the United States would fight a war as 50 separate states.”
Excerpts from United States Strains to Act as Cases Set Record, Science Magazine, Apr. 3, 2020, at 6488.